Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's disease

Recent news which mentions Alzheimer's disease

< Previous 1 2 3 Next >
The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks
Tags Make It / Life Dementia Make It
From CNBC.com News
Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning
Tickers TECH
Tags Startups Market News multiple sclerosis
From Benzinga
Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain
Tags Alzheimer's disease Make It / Power Players Podcasting
From CNBC.com News
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
Tickers POTX TOKE
Tags Markets Health Care Benzinga
From Benzinga
Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment
Tags Personal Income Personal Finance Retirement
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Health & Science Pharmaceuticals Health care industry
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Politics Policy Alzheimer's disease
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Companies Alzheimer's disease Science
From CNBC.com News
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
Tickers ALZN BIIB LLY SAVA
Tags Health Care alzheimer's treatment LLY
From Benzinga
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags Health care industry Biogen Inc Health & Science
From CNBC.com News
Alzheimer’s Disease, RSV, Migraines and more…
Tags Abbvie (ABBV) Teva Pharmaceuticals (TEVA) atrial fibrillation
From Stock Gumshoe
Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research
Tags Markets Exclusives Benzinga
From Benzinga
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags US Economy Eisai Co Ltd Biotech and Pharmaceuticals
From CNBC.com News
Medicare details plan to cover Alzheimer's treatments
Tags Health & Science Health care industry Politics
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Health care industry Biogen Inc Health & Science
From CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
Tags Business News Biotechnology World News
From CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Tags Health care industry Business News Biotechnology
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Eli Lilly and Co Eisai Co Ltd Biotech and Pharmaceuticals
From CNBC.com News
March 2023 Miscellany
Tags Doc Gumshoe Breast Cancer Cancer
From Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
Tags NervGen Pharma (NGEN/V NGENF) Doc Gumshoe Anavex Life Sciences (AVXL)
From Stock Gumshoe
Relevant Updates – December 2022
Tags Merck (MRK) Biogen Idec (BIIB) influenza
From Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
Tickers MOR RHHBF RHHBY RHHVF
Tags Trading Ideas Market News Biotech
From Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
Tags Exercise Smoking Twitter (delisted)
From CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
Tickers SPRC
Tags Markets Penny Stocks SciSparc Ltd/
From Benzinga
Odd & Ends – October 2022
Tags Alzheimer's Disease Amylx Pharmaceuticals (AMLX) ALS / Lou Gehrig's Disease
From Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Tickers ABOS ACIU ALZN ANVS
Tags BMY MOR Alzheimer’s
From Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags Analyst Color Market News Biotech
From Benzinga
Following Up on Your Suggestions – September 2022
Tickers DIET
Tags Doc Gumshoe vitamins diet
From Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
Tickers DGX
Tags Quest Diagnostics Dr Pat Alagia NYSE:DGX
From 3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
Tickers CGTX
Tags Benzinga CGTX General
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.